Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Arrowhead Pharmaceuticals (ARWR) over the last 15 years, with Q4 2025 value amounting to 0.73.

  • Arrowhead Pharmaceuticals' Asset Utilization Ratio rose 3133592.01% to 0.73 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.73, marking a year-over-year increase of 3133592.01%. This contributed to the annual value of 0.66 for FY2025, which is 1752528.31% up from last year.
  • According to the latest figures from Q4 2025, Arrowhead Pharmaceuticals' Asset Utilization Ratio is 0.73, which was up 3133592.01% from 0.6 recorded in Q3 2025.
  • Arrowhead Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.73 for Q4 2025, and its period low was 0.0 during Q4 2024.
  • Its 5-year average for Asset Utilization Ratio is 0.28, with a median of 0.3 in 2023.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 9911.09% in 2024, then surged by 3133592.01% in 2025.
  • Quarter analysis of 5 years shows Arrowhead Pharmaceuticals' Asset Utilization Ratio stood at 0.21 in 2021, then surged by 64.15% to 0.35 in 2022, then decreased by 25.72% to 0.26 in 2023, then tumbled by 99.11% to 0.0 in 2024, then skyrocketed by 31335.92% to 0.73 in 2025.
  • Its last three reported values are 0.73 in Q4 2025, 0.6 for Q3 2025, and 0.39 during Q2 2025.